FDA Inspection 910286 — Padagis Israel Pharmaceuticals Ltd.

Padagis Israel Pharmaceuticals Ltd. — FEI 3001904238

The FDA completed an inspection of Padagis Israel Pharmaceuticals Ltd. on January 22, 2015 in Yerucham. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 22, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Yerucham (Israel)